Weight Loss Injections

mounjaro vs wegovy

Mounjaro vs Wegovy

Pharmaceutical giant, Lilly, has launched a clinical trial that will compare the efficacy of their newly released drug, Mounjaro, with Novo Nordisk’s Wegovy in treating obesity. This head-to-head trial will evaluate the weight loss achieved by patients who take either Mounjaro or Wegovy over a period of 52 weeks. The trial will involve around 1,200 […]

Mounjaro vs Wegovy Read More »

Tirzepatide Weight Loss

Tirzepatide is a new medication that has shown promising results for weight loss and glycemic control in clinical trials. It is a glucagon-like peptide-1 (GLP-1) receptor agonist that also activates the glucagon and glucose-dependent insulinotropic polypeptide (GIP) receptors. It is being developed by Eli Lilly and Company and is currently in phase 3 clinical trials.

Tirzepatide Weight Loss Read More »

Semaglutide Benefits

Semaglutide is a medication used in the treatment of obesity and type 2 diabetes mellitus. It belongs to the class of drugs known as GLP-1 receptor agonists, which act on the GLP-1 receptor in the pancreas to stimulate insulin secretion and reduce glucagon secretion. Semaglutide is similar to the naturally occurring hormone glucagon-like peptide-1 (GLP-1),

Semaglutide Benefits Read More »